ENTPD1 and neoplasm: Third, extracellular vesicles (EVs) enriched in CD39, CD73, or ATP/AMP act as mobile metabolic platforms that enhance adenosine production and mediate long-range immunosuppression, integrating tumor cells, macrophages, and Tregs into a coordinated metabolic network (58, 77).